Re: effect of erythropoietin on kidney allograft survival: early use after transplantation.
نویسندگان
چکیده
Sir, We read with interest the article recently published in Iranian Journal of Kidney Diseases, titled “Effect of Erythropoietin on Kidney Allograft Survival: Early Use After Transplantation” by Yassari and colleagues.1 This study focused on the impact of recombinant human erythropoietin on graft survival during the six months after kidney transplantation. In a univariable analysis, they concluded that recombinant human erythropoietin may have favorable effects on renal allograft function when used immediate after transplantation. We agree that recombinant human erythropoietin is an independent immunomodulating agent and its receptor plays important costimulatory role on lymphocytes,2 and it prevents organs against cellular apoptosis as well as it increases the repair of damaged organ.1 It has an impact on non-specific and specific immunity.2 Thus, recombinant human erythropoietin may lead to improvement of renal allograft function due to its immunomodulatory effects after transplantation. It is of interest that Yassari and colleagues1 reported a higher glomerular filtration rate in kidney recipients who received recombinant human erythropoietin after transplantation compared to individuals taken placebo with no significantly difference in hemoglobin levels between two groups after 6 months. In a large retrospective study performed on 2713 adult kidney transplants, impaired renal allograft function was only risk factor associated with post-transplant anemia (odd ratio, 3.6; 95% confidence interval, 1.01 to 12.67; P = .047).3 Although the mean hemoglobin levels were not significantly different between both groups, the mean hemoglobin level in recipients received recombinant human erythropoietin was higher than those on placebo (11.6 ± 1.2 g/dL versus 11.2 ± 1.1 g/dL).1 It has been shown that posttransplant anemia was associated with worse renal allograft function.3-6 In addition, other study performed on 864 adult kidney transplants showed immediate anemia after kidney transplantation was strongly correlated with poor renal allograft function; moreover, immediate severe anemia was associated with delayed graft function (P = .01).7 Although, controversy exists concerning the overall effectiveness of recombinant human erythropoietin on kidney function among patients with chronic kidney disease,8 we agree that recombinant human erythropoietin therapy should be started early to avoid immediate anemia after kidney transplantation and its adverse events on graft function. It may be resulted in improvement kidney graft survival due to correction of anemia and its immunomodulatory effects on grafts. Finally, we suggest that further studies with larger samples size and longer period of follow up may be required to determine the impact of recombinant human erythropoietin therapy on kidney transplant outcome.
منابع مشابه
Effect of erythropoietin on kidney allograft survival: early use after transplantation.
INTRODUCTION Erythropoietin is administered for treatment of anemia in chronic kidney disease and kidney transplantation. Erythropoietin improves oxygenation of organs and prevents them against apoptosis. The aim of this study was evaluation of erythropoietin's effect on graft survival in the early phase after transplantation. MATERIALS AND METHODS Forty kidney transplant candidates with a he...
متن کاملComparison of Serum Cystatin C and Creati-nine Levels to Evaluate Early Renal Function after Kidney Transplantation
Background: Accurate and rapid assessment of allograft function is essential in renal transplant recipients in order to detect allograft rejection and to monitor drug nephrotoxicity. We aimed to evaluate the usefulness of cystatin C as a marker of kidney allograft function in the early post-transplant period and to compare this value with that of conventional serum creatinine concentration. Met...
متن کاملImmediate re-transplantation following early kidney transplant thrombosis.
Allograft thrombosis is a devastating early complication of renal transplantation that ultimately leads to allograft loss. We report here on our experience of nine cases of immediate re-transplantation following early kidney transplant thrombosis at a single centre between January 1990 and June 2009. The mean age was 42.9 years at time of transplant. For seven patients, the allograft thrombosis...
متن کاملEffect of Hypertonic Saline 5% on Early Graft Function and Urinary Interleukin 18 and Neutrophil Gelatinase-Associated Lipocalin in Deceased-Donor Kidney Transplantation
Ischemia reperfusion injury (IRI) is one of the main causes of delay graft function (DGF) in deceased-donor kidney transplantation (DDKT). Evidences suggest that hypertonic saline (HS) has beneficial effects on IRI. The objective of the present study is to determine the effect of intraoperative HS, on graft function and urinary biomarkers of interleukin 18 (IL-18) and neutrophil gelatinase-asso...
متن کاملEffect of Hypertonic Saline 5% on Early Graft Function and Urinary Interleukin 18 and Neutrophil Gelatinase-Associated Lipocalin in Deceased-Donor Kidney Transplantation
Ischemia reperfusion injury (IRI) is one of the main causes of delay graft function (DGF) in deceased-donor kidney transplantation (DDKT). Evidences suggest that hypertonic saline (HS) has beneficial effects on IRI. The objective of the present study is to determine the effect of intraoperative HS, on graft function and urinary biomarkers of interleukin 18 (IL-18) and neutrophil gelatinase-asso...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
برای دانلود متن کامل این مقاله و بیش از 32 میلیون مقاله دیگر ابتدا ثبت نام کنید
ثبت ناماگر عضو سایت هستید لطفا وارد حساب کاربری خود شوید
ورودعنوان ژورنال:
- Iranian journal of kidney diseases
دوره 7 4 شماره
صفحات -
تاریخ انتشار 2012